P-Selectin expression, platelet aggregates, and platelet-derived microparticle formation are increased in peripheral arterial disease

Blood Coagulation and Fibrinolysis

Volumn 11, Issue 8, 2000, Pages 723-728

  Zeiger, F ^a   Stephan, S ^a   Hoheisel, G ^a   Pfeiffer, D ^a   Ruehlmann, C ^a   Koksch, M ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Flow cytometry; Mean platelet volume; P selection; Peripheral arterial disease; Platelet aggregates; Platelet count; Platelet derived microparticles

Indexed keywords

PADGEM PROTEIN;

ADULT; AGED; ARTERY DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE VOLUME; VASCULAR DISEASE;

ADULT; BLOOD PLATELETS; CYTOPLASMIC GRANULES; HUMANS; MALE; MIDDLE AGED; P-SELECTIN; PERIPHERAL VASCULAR DISEASES; PLATELET AGGREGATION; PLATELET COUNT;

EID: 0034543087     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-200012000-00005     Document Type: Article

References (27)

1. Platelet size: Measurement, physiology and vascular disease
2. The platelet count and mean platelet volume
3. Platelet size in myocardial infarction
4. Platelet count, mean platelet volume and their relation to prognosis in cerebral infarction
5. Increased platelet volume and platelet mass in patients with atherosclerotic renal artery stenosis
6. Altered lipid compositions and thromboxane A2 formation in platelets from patients affected by IIa hyperlipoproteinaemia
7. Large platelets circulate in an activated state in diabetes mellitus
8. Diabetics with peripheral vascular disease have an increased mean platelet volume and megakaryocyte ploidy
9. Direct detection of activated platelets and platelet-derived microparticles in humans
10. Platelet microparticles: A wide-angle perspective
11. Platelet aggregates as markers of platelet activation: Characteristic flow cytometric method suitable for clinical applications
12. Laboratory markers of platelet activation and their clinical significance
13. Suggested standards for reports dealing with lower extremity ischemia
14. Markers of platelet activation in coronary heart disease patients
15. Platelet function in acute myocardial infarction treated with direct angioplasty
16. Cardiopulmonary bypass leads to a preferential loss of activated platelets
17. Platelet activation mechanisms and markers in arterial thrombosis
18. Peripheral occlusive disease - Correlation of disease progression and platelet and coagulation parameters
19. Coagulation activities of plasma microparticles
20. Platelet microparticles and calcium homeostasis in acute coronary ischemias
21. Elevated platelet microparticles in transient ischemic attacks, lacunar infarcts, and multiinfarct dementias
22. Clinical significance of platelet microparticles in auto-immune thrombocytopenias
23. Selectins
24. A sensitive flow cytometic assay for circulating platelet-leucocyte aggregates
25. Megakaryocytes and platelets in vascular disease
26. Influence of platelet size on outcome after myocardial infarction
27. Platelet size, fibrinogen and lipoprotein (a) in coronary heart disease